Saruwatari Dermatology Clinic

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Psoriasis4 trials

Phase

• Phase 34 trials

Status

• Completed3 trials
• Active, not recruiting1 trial

Lead sponsor

• Alumis Inc2 trials
• Amgen1 trial
• Takeda1 trial

Running trials

• Active, not recruiting

  Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis

  NCT06846541· Phase 3· Alumis Inc· Source

Closed trials

• Completed

  A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Moderate to Severe Plaque Psoriasis

  NCT06586112· Phase 3· Alumis Inc· Source

• Completed

  A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment

  NCT06088043· Phase 3· Takeda· Source

• Completed

  A Study to Assess the Efficacy and Safety of Apremilast in Japanese Pediatric Participants With Moderate to Severe Plaque Psoriasis

  NCT05565560· Phase 3· Amgen· Source